Recent Updates
Recently added Catalysts
ZBH Positive Sentiment

Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Jehanzeb Noor is joining the Company as...

Key Takeaway: Zimmer Biomet has appointed Jehanzeb Noor as Senior Vice President and Chief Strategy, Innovation and Business Development Officer. Noor will oversee strategy development, M&A activities, and product development, including the integration of the pending acquisition of Paragon 28. His previous roles include leadership positions at Trivium and Smiths Medical.
Price reaction · baseline $104.92 (2025-02-26 close) · hit after-hours · 1 other ZBH headline(s) in the window, move may be shared
day 0 close · peak
-0.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Jehanzeb Noor brings extensive experience in strategy and innovation.
  • His appointment is expected to enhance Zimmer Biomet's execution and culture.
  • The company is pursuing innovation and strategic acquisitions.

Full Press Release Details

WARSAW, Ind. , Feb. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Jehanzeb Noor is joining the Company as Senior Vice President, Chief Strategy, Innovation and Business Development Officer. He will report to Ivan Tornos, President and CEO of Zimmer Biomet.
In his new role, Mr. Noor will be responsible for leading strategy development and execution and all facets of M&A, including the integration for our pending acquisition of Paragon 28. In addition, he will have oversight of the research and product development organizations, inclusive of new product and service development, partnership and ecosystem development, and platform technologies. He will also serve as the Chief of Staff to the CEO.
In his new role, Mr. Noor will be responsible for leading strategy development and execution and all facets of M&A, including the integration for our pending acquisition of Paragon 28. In addition, he will have oversight of the research and product development organizations, inclusive of new product and service development, partnership and ecosystem development, and platform technologies. He will also serve as the Chief of Staff to the CEO.
"I'm thrilled to welcome Jehanzeb to Zimmer Biomet," said Mr. Tornos. "Over the course of his career, Jehanzeb has consistently demonstrated an impressive track record of significantly improving execution, culture and results. As we continue to boldly execute against our strategy and pursue innovation, I am confident Jehanzeb will be instrumental to our long-term success and deliver value for patients, surgeons, health systems and shareholders."
Prior to Zimmer Biomet, Mr. Noor served as President and Managing Director for Europe , Africa , and Asia at Trivium, where he led Trivium's top & bottom-line transformation to drive operational excellence for margin and cash expansion. Prior to Trivium, Mr. Noor was CEO of Smiths Medical for three years and also held roles of increasing responsibility at Amcor, McKinsey, Ford Motor Company, and Constellation Energy Commodities Group.
Mr. Noor holds a Master of Science with a focus on Product Development, a Bachelor of Science in Finance and a Bachelor of Science in Mechanical Engineering, all from the Massachusetts Institute of Technology ( MIT ).
About Zimmer Biomet Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet .
Media
Investors
Heather Zoumas-Lubeski
David DeMartino
445-248-0577
646-531-6115
[email protected]
[email protected]
Zach Weiner
908-591-6955
[email protected]

Frequently Asked Questions

Who is Jehanzeb Noor?

Jehanzeb Noor is the newly appointed Senior Vice President and Chief Strategy Officer at Zimmer Biomet.

What will Noor's responsibilities include?

Noor will lead strategy development, M&A activities, and oversee product development.

What is Noor's previous experience?

He previously served as President at Trivium and CEO of Smiths Medical.

What acquisition is Noor involved with?

He will oversee the integration of the pending acquisition of Paragon 28.

Last updated: Feb 27, 2025